Cargando…
Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
BACKGROUND: Glioma is the most common primary brain tumor in adults with poor prognosis. The glioma patients benefit from STUPP strategy, including maximum and safe resection and adjuvant radiotherapy and chemotherapy. Arsenic trioxide could inhibit various tumors. However, it is a challenge to eval...
Autores principales: | Han, Dayong, Teng, Lei, Wang, Xiaoxiong, Zhen, Yunbo, Chen, Xiaofeng, Yang, Mingchun, Gao, Ming, Yang, Guang, Han, Mingyang, Wang, Ligang, Xu, Jiajun, Li, Yue, Shumadalova, Alina, Zhao, Shiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535358/ https://www.ncbi.nlm.nih.gov/pubmed/36212657 http://dx.doi.org/10.3389/fneur.2022.1001829 |
Ejemplares similares
-
The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas
por: Wang, Chunlei, et al.
Publicado: (2014) -
Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells
por: Sun, Yuanyuan, et al.
Publicado: (2018) -
Therapeutic effect of natural polyphenols against glioblastoma
por: Beylerli, Ozal, et al.
Publicado: (2022) -
Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020) -
Arsenic trioxide as a novel anti-glioma drug: a review
por: Fang, Yi, et al.
Publicado: (2020)